|
17 Feb 2021 |
Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis
|
|
16 Feb 2021 |
Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
|
|
16 Feb 2021 |
Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important Pediatric and Adult Deafness Segments
|
|
16 Feb 2021 |
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
|
|
09 Feb 2021 |
Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial
|
|
05 Feb 2021 |
Imcyse Enters into Research Collaboration and License Agreement for its Imotope™ Technology with Pfizer in Rheumatoid Arthritis
|
|
03 Feb 2021 |
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
|
|
02 Feb 2021 |
X-Chem Enters into Multitarget Oncology Discovery Research Collaboration and License Agreement with Genentech
|
|
02 Feb 2021 |
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
|
|
01 Feb 2021 |
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure
|
|
01 Feb 2021 |
Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio
|
|
25 Jan 2021 |
Evozyne and Takeda Announce Strategic Collaboration and License Agreement
|
|
21 Jan 2021 |
Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
|
|
20 Jan 2021 |
Turnstone Biologics Acquires Novel Cell Therapy Platform
|
|
18 Jan 2021 |
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
|
|
15 Jan 2021 |
Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases
|
|
15 Jan 2021 |
Syntekabio Signs Joint Development Agreement with Hanmi Science
|
|
13 Jan 2021 |
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
|
|
13 Jan 2021 |
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
|
|
13 Jan 2021 |
Actinium and Astellas Announce Research Collaboration Focused on Novel Actinium-225 Based Targeted Radiotherapies
|
|
12 Jan 2021 |
La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe
|
|
12 Jan 2021 |
Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
|
|
11 Jan 2021 |
Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs
|
|
11 Jan 2021 |
Eligo Bioscience inks deal with GSK potentially worth up to $224 million
|
|
10 Jan 2021 |
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
|
